Screener
Lexicon Pharmaceuticals LXRX Cash Flow Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| -$31.78M-1,077% | -$1.04M+95.9% | -$15.53M+54.0% | -$12.77M+80.3% | $3.25M+106% | ||
| $102K-42.0% | $110K-37.5% | $118K-5.6% | $151K+19.8% | $176K+26.6% | ||
| $3.34M+4.4% | $3.08M+1.2% | $2.84M+84.5% | $3.44M+23.0% | $3.2M-34.2% | ||
| -$9.19M— | -$14.73M+66.4% | -$17.23M+19.8% | -$23.83M+55.6% | —— | ||
| -$16.46M-206% | -$70.26M-273% | $4.83M— | $52.13M— | $15.48M+226% | ||
| —— | —— | $0— | $0— | $0— | ||
| $54.26M+20.6% | $5M— | $3M— | $0— | $45M— | ||
| —— | $88.76M+15,617% | -$2.93M— | $0— | -$45M— | ||
| -$26.17M-109% | $3.76M+200% | -$15.33M-148% | $28.29M— | -$12.52M— |
FAQ
- How much cash does Lexicon Pharmaceuticals generate?
- Lexicon Pharmaceuticals (LXRX) generated -$65.0M in operating cash flow over the trailing twelve months.
- Where does Lexicon Pharmaceuticals's cash flow data come from?
- Every line is extracted from Lexicon Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
